BPC-157 has been reported to upregulate VEGFR2 (vascular endothelial growth factor receptor 2) and activate the Akt-eNOS pathway, which raises nitric oxide production in blood-vessel walls (Hsieh et al., Journal of Molecular Medicine, 2017
Safety Considerations While no direct pharmacological interaction exists between BPC-157 and GLP-1 medications, responsible use requires attention to several factors
Microorganisms, 10 (9), 1838
Full reconstitution guide Advanced calculator Dosing & Reconstitution Guide Two reconstitution strategies with accurate daily dosing, step by step Standard / Gradual Approach (3 mL = ~3,333 mcg/mL) Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg vial final concentration: ~3,333 mcg/mL
Inject slowly over say 30 seconds then withdraw the needle